Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
In retirement, choosing between Sp500 and Total Market matters. This guide outlines criteria to select the better fit for your horizon and risk profile.
28,409 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
A major cold storage leader caught the eye of a notable investor, who disclosed a fresh stake worth $19 million. This...
Palantir Technologies presents a paradox: strong fundamentals on one hand, a volatile stock on the other. This articl...
Tom Steyer poured $216 million of his own money into a California governor bid, a record in modern campaigns. The spe...
Alphabet blew past expectations with a robust earnings beat and a cloud backlog that leapt to $460 billion, signaling...
Is Micron stock under a lofty price point worth buying? This article breaks down the key factors, including memory ma...
VOOG surged in a blistering rally before facing headwinds as rates climbed and big tech leadership shifted. Here's wh...
A single, massive swap stirred chaos in the DeFi space when extreme slippage warnings were ignored. The trader receiv...
The Senate Banking Committee kicks off markup on the Digital Asset Market Clarity Act as amendments mount and ethics ...
Oracle's backlog surge and accelerating AI infrastructure growth are fueling a heated debate on whether the stock is ...
Ready to build a crypto portfolio for the long haul? This guide breaks down the best altcoins for long-term investmen...
Netflix faces a pivotal July 16 earnings date. This article breaks down the three main reasons the stock needs convin...